Literature DB >> 19533707

A stereodivergent strategy to both product enantiomers from the same enantiomer of a stereoinducing catalyst: agelastatin A.

Barry M Trost1, Guangbin Dong.   

Abstract

In this article, we report a full account of our recent development of pyrroles and N-alkoxyamides as new classes of nucleophiles for palladium-catalyzed AAA reactions, along with application of these methodologies in the total synthesis of agelastatin A, a marine natural product with exceptional anticancer activity and other biological properties. Our method allows for access to either regioisomer of the pyrrolopiperazinones (6 and 19) with high efficiency and enantioselectivity. Note that isomer 19 was obtained via a cascade reaction through a double allylic alkylation pathway. From regioisomer 6, the total synthesis of (+)-agelastatin A was completed in a very short fashion (four steps from 6), during the course of which we developed a new copper catalyst for aziridination and an In(OTf)(3)/DMSO system to oxidatively open an N-tosyl aziridine. Starting with the other pyrrolopiperazinone 19, a five-step sequence has been developed to furnish a formal total synthesis of (-)-agelastatin A. A unique feature of our syntheses is the use of two rather different strategies for the total syntheses of both enantiomers of agelastatin A using the same enantiomer of a chiral palladium catalyst.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19533707      PMCID: PMC2914473          DOI: 10.1002/chem.200900794

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  23 in total

1.  Enantiospecific formal total synthesis of the tumor and GSK-3 beta inhibiting alkaloid, (-)-agelastatin A.

Authors:  Karl J Hale; Mathias M Domostoj; Derek A Tocher; Ed Irving; Feodor Scheinmann
Journal:  Org Lett       Date:  2003-08-07       Impact factor: 6.005

2.  Asymmetric transition-metal-catalyzed allylic alkylations: applications in total synthesis.

Authors:  Barry M Trost; Matthew L Crawley
Journal:  Chem Rev       Date:  2003-08       Impact factor: 60.622

3.  New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.

Authors:  Mathias M Domostoj; Ed Irving; Feodor Scheinmann; Karl J Hale
Journal:  Org Lett       Date:  2004-07-22       Impact factor: 6.005

4.  Agelastatins C and D, new pentacyclic bromopyrroles from the sponge Cymbastela sp., and potent arthropod toxicity of (-)-agelastatin A.

Authors:  T W Hong; D R Jímenez; T F Molinski
Journal:  J Nat Prod       Date:  1998-01       Impact factor: 4.050

5.  New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.

Authors:  Barry M Trost; Guangbin Dong
Journal:  J Am Chem Soc       Date:  2006-05-10       Impact factor: 15.419

6.  Complete control of the chemoselectivity in catalytic carbene transfer reactions from ethyl diazoacetate: an N-heterocyclic carbene-Cu system that suppresses diazo coupling.

Authors:  Manuel R Fructos; Tomás R Belderrain; M Carmen Nicasio; Steven P Nolan; Harneet Kaur; M Mar Díaz-Requejo; Pedro J Pérez
Journal:  J Am Chem Soc       Date:  2004-09-08       Impact factor: 15.419

7.  Alkynyliodonium salts in organic synthesis. Application to the total synthesis of (-)-agelastatin A and (-)-agelastatin B.

Authors:  Ken S Feldman; Joe C Saunders
Journal:  J Am Chem Soc       Date:  2002-08-07       Impact factor: 15.419

8.  Aziridination of aliphatic alkenes catalyzed by N-heterocyclic carbene copper complexes.

Authors:  Qun Xu; Daniel H Appella
Journal:  Org Lett       Date:  2008-03-12       Impact factor: 6.005

9.  Alkynyliodonium salts in organic synthesis. Development of a unified strategy for the syntheses of (-)-agelastatin A and (-)-agelastatin B.

Authors:  Ken S Feldman; Joe C Saunders; Michelle Laci Wrobleski
Journal:  J Org Chem       Date:  2002-10-04       Impact factor: 4.354

10.  Highly selective oxidative cleavage of beta-cyclodextrin-epoxide/aziridine complexes with IBX in water.

Authors:  K Surendra; N Srilakshmi Krishnaveni; M Arjun Reddy; Y V D Nageswar; K Rama Rao
Journal:  J Org Chem       Date:  2003-11-14       Impact factor: 4.354

View more
  9 in total

1.  Palladium-catalyzed asymmetric allylic alkylation of electron-deficient pyrroles with meso electrophiles.

Authors:  Barry M Trost; Maksim Osipov; Guangbin Dong
Journal:  Org Lett       Date:  2012-04-16       Impact factor: 6.005

2.  Pd and Mo Catalyzed Asymmetric Allylic Alkylation.

Authors:  Barry M Trost
Journal:  Org Process Res Dev       Date:  2012-01-13       Impact factor: 3.317

3.  Synthesis and Evaluation of Agelastatin Derivatives as Potent Modulators for Cancer Invasion and Metastasis.

Authors:  Alyssa H Antropow; Kun Xu; Rachel J Buchsbaum; Mohammad Movassaghi
Journal:  J Org Chem       Date:  2017-07-25       Impact factor: 4.354

4.  Bioinspired total synthesis of agelastatin A.

Authors:  Jeremy Chris P Reyes; Daniel Romo
Journal:  Angew Chem Int Ed Engl       Date:  2012-06-11       Impact factor: 15.336

5.  Synthesis and anticancer activity of all known (-)-agelastatin alkaloids.

Authors:  Sunkyu Han; Dustin S Siegel; Karen C Morrison; Paul J Hergenrother; Mohammad Movassaghi
Journal:  J Org Chem       Date:  2013-11-21       Impact factor: 4.354

Review 6.  Biosynthesis, asymmetric synthesis, and pharmacology, including cellular targets, of the pyrrole-2-aminoimidazole marine alkaloids.

Authors:  Ali Al-Mourabit; Manuel A Zancanella; Supriya Tilvi; Daniel Romo
Journal:  Nat Prod Rep       Date:  2011-05-09       Impact factor: 13.423

7.  Total synthesis of all (-)-Agelastatin alkaloids.

Authors:  Mohammad Movassaghi; Dustin S Siegel; Sunkyu Han
Journal:  Chem Sci       Date:  2010-01-01       Impact factor: 9.825

8.  Metal Catalyzed Allylic Alkylation: Its Development in the Trost Laboratories.

Authors:  Barry M Trost
Journal:  Tetrahedron       Date:  2015-09-02       Impact factor: 2.457

Review 9.  A submarine journey: the pyrrole-imidazole alkaloids.

Authors:  Barbara Forte; Beatrice Malgesini; Claudia Piutti; Francesca Quartieri; Alessandra Scolaro; Gianluca Papeo
Journal:  Mar Drugs       Date:  2009-11-27       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.